MedTrace Logo

Screening for Albuminuria at the First Line for Early Identification of CKD

NCT05321095 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 141

Last updated 2024-08-09

No results posted yet for this study

Summary

Early detection of kidney disease

Conditions

Interventions

DIAGNOSTIC_TEST

Albuminuria test

During participation, subjects are asked to collect one or more urine samples for albuminuria determination.

DIAGNOSTIC_TEST

HbA1c test

During the screening visit, HbA1c will be measured with a point-of-care test (Affinion HbA1c, Abbott).

DIAGNOSTIC_TEST

Creatinine test

During the screening visit, creatinine will be measured with a point-of-care test (i-STAT Alinity handheld analyser, Abbott).

Sponsors & Collaborators

  • University Medical Center Groningen

    collaborator OTHER

  • General Practitioners Research Institute

    lead NETWORK

Principal Investigators

  • H.J. Lambers Heerpink, Prof. dr. · UMCG

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-25
Primary Completion
2023-12-31
Completion
2024-07-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05321095 on ClinicalTrials.gov